共 16 条
[1]
Current and emerging nonsteroidal anti-in- flammatory therapies targeting specific mechanisms in asthma and al-lergy. Bjermer L,Diamant Z. Treatments in Respiratory Medicine . 2004
[3]
Respiratory syncytial virus infection and asthma. Martin MA. Al- lergol Immunopathol . 2001
[4]
Effects of interleukin - 18 on asthmatic airway inflammation. Zhang H,Zhang Z,Xu Y. Chinese Medical Journal . 2003
[5]
Low numbers of interleukin - 12 - producing cord blood mononuclear cells and im-munoglobulin E sensitization in early childhood. Nilsson C,Larsson AK,Hoglind A,et al. Clinical and Experimental Allergy . 2004
[6]
Respiratory development of 5 to 6 year - old children experiencing a first bronchiolitis episode before age one. Sznajder M,Stheneur C,Albonico V,et al. Allerg Immunol (Paris) . 2005
[7]
Interliukin (IL) - 18 promotes the development of chronic gastrointestinal helminth infection by downre-gulating IL- 13. Helena H,Kiyoshi T,Shizuo A,et al. The Journal of Experimental Medicine . 2001
[8]
Decreased inter-liukin - 12 levels in umbilical cord blood in children who developed a-cute broncholitis. Blanco -Quriros A,Gonzalez H,Arranz E,et al. Pediatric Pulmonology . 1999
[9]
In vitro responsiveness to IL-18 in combination with IL - 12 or IL - 2 by PBMC from patients with bronchial asthma and atopic dermatitis. El-Mezayen RE,Matsumoto T. Clinical Immunology . 2004
[10]
IL- 12 p40 and IL- 18 modulate inflammatory and immune responses to respiratory syncytial virus infection. Wang SZ,Bao YX,Rosenberger CL. J Immunol . 2004